WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Stock Ownership - Who owns Terns Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Terns Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Emil KuriakoseChief Medical Officer2026-04-01942$52.75
$49.69kSell
Amy L. BurroughsChief Executive Officer2026-03-162,770$47.30
$131.03kSell
Amy L. BurroughsChief Executive Officer2026-03-1614,583$4.64
$67.67kBuy
Amy L. BurroughsChief Executive Officer2026-03-1611,813$46.57
$550.08kSell
Amy L. BurroughsChief Executive Officer2026-02-1714,583$4.64
$67.67kBuy
Amy L. BurroughsChief Executive Officer2026-02-172,341$38.07
$89.11kSell
Amy L. BurroughsChief Executive Officer2026-02-178,159$39.22
$319.96kSell
Amy L. BurroughsChief Executive Officer2026-02-174,083$39.80
$162.50kSell
Amy L. BurroughsChief Executive Officer2026-01-1527,083$4.64
$125.67kBuy
Amy L. BurroughsChief Executive Officer2026-01-1514,583$4.64
$67.67kBuy

1 of 3

TERN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TERN insiders and whales buy or sell their stock.

TERN Shareholders

What type of owners hold Terns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Opportunity LLC10.00%11,536,701$610.75MInsider
Blackrock Inc7.10%8,194,218$433.80MInstitution
Morgan Stanley6.88%7,945,608$420.64MInstitution
Adage Capital Partners GP LLC4.81%5,550,000$293.82MInstitution
Vanguard Group Inc4.79%5,523,948$292.44MInstitution
Vivo Capital LLC4.63%5,346,928$283.07MInstitution
Vestal Point Capital LP3.90%4,500,000$238.23MInstitution
Avoro Capital Advisors LLC3.77%4,350,000$230.29MInstitution
Janus Henderson Group PLC2.93%3,379,569$178.91MInstitution
Citadel Advisors LLC2.74%3,166,642$167.64MInstitution

1 of 3

TERN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TERN85.84%14.16%Net SellingNet Selling
CNTA91.12%8.88%Net BuyingNet Selling
BLTE18.27%1.12%Net SellingNet Selling
PTGX82.89%17.11%Net SellingNet Selling
COGT92.60%7.40%Net SellingNet Selling
View Top Biotech Stocks

Terns Pharmaceuticals Stock Ownership FAQ

Who owns Terns Pharmaceuticals?

Terns Pharmaceuticals (NASDAQ: TERN) is owned by 108.78% institutional shareholders, 17.95% Terns Pharmaceuticals insiders, and 0.00% retail investors. Vivo Opportunity LLC is the largest individual Terns Pharmaceuticals shareholder, owning 11.54M shares representing 10.00% of the company. Vivo Opportunity LLC's Terns Pharmaceuticals shares are currently valued at $610.52M.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.